Aligos Therapeutics ALGS
NASDAQ ALGS
$5.23 +0.20 (+4.15%)
As of: Oct 21, 2026 · 10:39 AM EDT

Aligos Therapeutics (ALGS) Operating Expenses (2019 - 2026)

Updated

Aligos Therapeutics (ALGS) recorded Operating Expenses of $29.67 million in Q2 2026, up 51.9% from $19.53 million a year earlier but down 0.3% from the prior quarter.

Analysis

Aligos Therapeutics (ALGS) Operating Expenses (2019 - 2026) Analysis & Trends

On a TTM basis, Aligos Therapeutics' Operating Expenses came in at $110.51 million as of Jun 30, 2026, up 35.3% year-over-year; for FY2025, it came in at $90.17 million, down 3.1% from FY2024.

  • Annual Operating Expenses has declined for four straight years, with a five-year compound annual growth rate of -1.6% (FY2020 to FY2025).
  • Across earlier years, Operating Expenses came in at $93.1 million in FY2024 (-10.2%), $103.66 million in FY2023 (-7.0%), $111.49 million in FY2022 (-16.0%) and $132.68 million in FY2021 (+35.6%).
  • Quarterly Operating Expenses has ranged from $19.53 million in Q2 2025 to $38.32 million in Q4 2021 over the past five years.
  • On a year-over-year basis, Operating Expenses has increased for four consecutive quarters, with growth averaging 8.7% over the last eight quarters.
  • Peak year-over-year performance for Operating Expenses in the last five years was growth of 60.5% in Q3 2021, against a decline of 33.4% in Q3 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $29.76 million (Q1 2026), $21.98 million (Q4 2025) and $29.1 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Eli Lilly 1,132.46 Bn 1,101.04 Bn 19.71 Bn 7.95 Bn
2 Johnson & Johnson 614.45 Bn 532.98 Bn 17.26 Bn 10.12 Bn
3 AbbVie 503.76 Bn 476.87 Bn 12.70 Bn 10.56 Bn
4 Merck 367.67 Bn 322.05 Bn 12.21 Bn 12.80 Bn
5 Novartis Ag 298.09 Bn 262.08 Bn 11.24 Bn 6.09 Bn
6 Astrazeneca 261.81 Bn 235.50 Bn 12.86 Bn 9.70 Bn
7 Amgen 236.49 Bn 191.89 Bn 7.24 Bn 6.54 Bn
8 Gilead Sciences 191.25 Bn 165.45 Bn 6.22 Bn 18.20 Bn
9 Pfizer 170.18 Bn 116.83 Bn 10.94 Bn 6.68 Bn
10 Aligos Therapeutics 54.60 Mn -273.80 Mn - 29.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 29.67 Mn
Mar 31, 2026 29.76 Mn
Dec 31, 2025 21.98 Mn
Sep 30, 2025 29.10 Mn
Jun 30, 2025 19.53 Mn
Mar 31, 2025 19.55 Mn
Dec 31, 2024 21.19 Mn
Sep 30, 2024 21.40 Mn
Jun 30, 2024 27.48 Mn
Mar 31, 2024 23.03 Mn
Dec 31, 2023 28.68 Mn
Sep 30, 2023 22.31 Mn
Jun 30, 2023 26.03 Mn
Mar 31, 2023 26.64 Mn
Dec 31, 2022 26.22 Mn
Sep 30, 2022 23.05 Mn
Jun 30, 2022 24.09 Mn
Mar 31, 2022 38.13 Mn
Dec 31, 2021 38.32 Mn
Sep 30, 2021 34.61 Mn
API Access

Aligos Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=ALGS&period=max&api_key=YOUR_API_KEY